comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 09:45:10 - browse：49

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Biden’s NIH nominee is languishing in Congress

WSS

Study finds gene variants tied to breast cancer risk in Black women

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Scrutiny of post

Digital health: a case of mistaken identity

Questions and answers about ramping up H5N1 bird flu vaccine

Home health providers sue Medicare over payment cuts

explore

comprehensive

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ACA's risk program benefits Blue Cross Blue Shield insurers

In Memoriam: Notable people who died in 2023

UnitedHealth argues against case alleging wrongful AI care denials

As demand for Covid shots wanes, Moderna seeks its next success

Making the case for fair compensation in clinical trials

Apple is now the first public company to be valued at $3 trillion

Citing H5N1 threat, CDC urges peak flu monitoring this summer

How one medical school became remarkably diverse

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

explore

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

White House announces new plan to address the growing threat of xylazine in overdose crisis

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

UnitedHealth argues against case alleging wrongful AI care denials

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

hotspot

hotspot

focus

hotspot